Encirclement of the eye as part of a retinal detachment repair is known to raise the post-operative intraocular pressure. We studied the effect of anticipating this pressure rise by giving perioperative acetazolamide to patients having vitrectomy and encirclement proce dures. Two groups (9 with acetazolamide and 14 without) were matched for biographic variables, type of detachment and operation variables. The group given acetazolamide had lower day 1 post-operative intra ocular pressures (mean 22.11 mmHg vs 36.36 mmHg, p = 0.002) and were able to go home sooner (mean 1.56 days vs 3.29 days, p = 0.001). No adverse effects of short-term acetazolamide use were noted in this study.
short-term acetazolamide use were noted in this study.
We conclude that patients having extensive scleral buckling procedures should all receive prophylactic acetazolamide unless it is specifically contraindicated.
Scleral buckling for retinal detachment is associated with raised post-operative intraocular pressure. This is particularly the case when the eye has been encircled. I -3 The result is post-operative pain, slower recovery and longer hospital stays.
Acetazolamide lowers intraocular pressure. 4 This study looked at whether pre-treating patients under going retinal detachment surgery and encirclement with acetazolamide, either during surgery or imme diately post-operatively, reduces the post-operative pressure, pain or stay in hospital.
MATERIALS AND METHODS
Two groups of patients undergoing retinal detach ment surgery were compared retrospectively. Patients satisfying eligibility criteria were drawn from all those undergoing retinal detachment surgery between June 1989 and July 1993. Both groups had vitrectomy and encirclement as part of their pro- cedure. The trial group had 500 mg acetazolamide either intravenously during the operation or in the early post-operative period. The control group did not. Patients with any conditions that could interfere independently with intraocular pressure such as previous eye surgery (apart from uncomplicated extracapsular cataract extraction with lens implant), glaucoma, diabetes or inflammatory eye disease, or age over 70 years, were excluded.
All patients underwent retinal cryopexy, subretinal fluid drainage, airlfluid exchange and SF6 gas injection. The encircling element was a 240 Mira strap and the buckle was either a 277 or 279 sutured directly to sclera and placed circumferentially. No silicone oil was used in this study. The outcome parameters assessed were the intraocular pressure on the first post-operative day, the need for post operative opiate analgesia and the length of stay in hospital. An observer masked to the study groups assessed the indications for prolonged hospital stays in those patients who stayed longer than 1 day. Student's {-test assuming unequal variance was used for analysis of intraocular pressure and length of hospital stay, while Fisher's exact test was used for analysis of post -operative analgesia.
RESULTS
Fourteen patients did not receive acetazolamide and 9 did. Details of the patients are listed in Table I and the parameters that were compared between the groups in Table II .
The mean first day intraocular pressure was 22.11 mmHg (SD 6.39 mmHg) in the acetazolamide group and 36.36 (SD 13.20 mmHg) in the untreated group. This difference is significant (p = 0.002), with a difference between means of 14.25 and 95 % con fidence intervals of 5.6 to 22.9.
The mean number of days in hospital was 1.56 (SD 0.73) in the treated group and 3.29 (SD 1.49) in the untreated group. This was significant (p = 0.001),
Eye (1996) 10, 328-330 © 1996 Royal College of Ophthalmologists Acetazolamide has short-term side effects (drowsi ness, numbness, tingling of extremities, fatigue, excitement, thirst, headache, dizziness, ataxia, tinni tus, hearing loss, gastrointestinal disturbances, aller gic reactions), none of which were documented in the records of the patients in this study.
